Molecular Weight:   | 272.07 |
Volume:   | 273.743 |
LogP:   | 2.639 |
LogD:   | 2.528 |
LogS:   | -2.993 |
# Rotatable Bonds:   | 3 |
TPSA:   | 97.99 |
# H-Bond Aceptor:   | 5 |
# H-Bond Donor:   | 4 |
# Rings:   | 2 |
# Heavy Atoms:   | 5 |
QED Drug-Likeness Score:   | 0.391 |
Synthetic Accessibility Score:   | 2.225 |
Fsp3:   | 0.0 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Accepted |
GSK Rule:   | Accepted |
BMS Rule:   | 0 |
Golden Triangle Rule:   | Accepted |
Chelating Alert:   | 1 |
PAINS Alert:   | 1 |
Caco-2 Permeability:   | -4.931 |
MDCK Permeability:   | 1.1079420801252127e-05 |
Pgp-inhibitor:   | 0.012 |
Pgp-substrate:   | 0.014 |
Human Intestinal Absorption (HIA):   | 0.022 |
20% Bioavailability (F20%):   | 0.152 |
30% Bioavailability (F30%):   | 0.19 |
Blood-Brain-Barrier Penetration (BBB):   | 0.029 |
Plasma Protein Binding (PPB):   | 99.30765533447266% |
Volume Distribution (VD):   | 0.466 |
Pgp-substrate:   | 1.4295717477798462% |
CYP1A2-inhibitor:   | 0.89 |
CYP1A2-substrate:   | 0.113 |
CYP2C19-inhibitor:   | 0.218 |
CYP2C19-substrate:   | 0.048 |
CYP2C9-inhibitor:   | 0.611 |
CYP2C9-substrate:   | 0.825 |
CYP2D6-inhibitor:   | 0.449 |
CYP2D6-substrate:   | 0.704 |
CYP3A4-inhibitor:   | 0.797 |
CYP3A4-substrate:   | 0.145 |
Clearance (CL):   | 16.32 |
Half-life (T1/2):   | 0.924 |
hERG Blockers:   | 0.06 |
Human Hepatotoxicity (H-HT):   | 0.283 |
Drug-inuced Liver Injury (DILI):   | 0.682 |
AMES Toxicity:   | 0.826 |
Rat Oral Acute Toxicity:   | 0.649 |
Maximum Recommended Daily Dose:   | 0.662 |
Skin Sensitization:   | 0.959 |
Carcinogencity:   | 0.509 |
Eye Corrosion:   | 0.031 |
Eye Irritation:   | 0.956 |
Respiratory Toxicity:   | 0.299 |
Natural Product ID:   | NPC26697 |
Common Name*:   | Butein |
IUPAC Name:   | (E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one |
Synonyms:   | 3,4,2',4'-Tetrahydroxychalone; Butein |
Standard InCHIKey:   | AYMYWHCQALZEGT-ORCRQEGFSA-N |
Standard InCHI:   | InChI=1S/C15H12O5/c16-10-3-4-11(14(19)8-10)12(17)5-1-9-2-6-13(18)15(20)7-9/h1-8,16,18-20H/b5-1+ |
SMILES:   | Oc1ccc(c(c1)O)C(=O)/C=C/c1ccc(c(c1)O)O |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL128000 |
PubChem CID:   |
5281222 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO3634 | Robinia pseudoacacia | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[11551759] |
NPO28952 | Sapium haematospermum | Species | Euphorbiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[15104489] |
NPO223 | Rhaponticum carthamoides | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[15730237] |
NPO23510 | Vicia faba | Species | Fabaceae | Eukaryota | flowers | n.a. | n.a. |
PMID[16180811] |
NPO32846 | heamatoxylon campechianum | Species | n.a. | n.a. | stems | XiShuangBanNa, Yunnan Province, China | 2005-Sep |
PMID[18610999] |
NPO2188 | Dendrobium candidum | Species | Orchidaceae | Eukaryota | n.a. | stem | n.a. |
PMID[19182417] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[20815207] |
NPO3634 | Robinia pseudoacacia | Species | Fabaceae | Eukaryota | n.a. | whole plant | n.a. |
PMID[21214467] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | root | n.a. |
PMID[21319773] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | leaf | n.a. |
PMID[21319773] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | bark | n.a. |
PMID[21319773] |
NPO26559 | Glycine soja | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[21545185] |
NPO23510 | Vicia faba | Species | Fabaceae | Eukaryota | n.a. | leaf | n.a. |
PMID[22014228] |
NPO23510 | Vicia faba | Species | Fabaceae | Eukaryota | n.a. | branch | n.a. |
PMID[22014228] |
NPO23510 | Vicia faba | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[22014228] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | leaf | n.a. |
PMID[22207282] |
NPO18117 | Dalbergia odorifera | Species | Fabaceae | Eukaryota | heartwood | n.a. | n.a. |
PMID[23743282] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | root | n.a. |
PMID[23806866] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | root bark | University of Veterinary and Pharmaceutical Sciences Brno (UVPS Brno), Brno, Czech Republic | 2011-APR |
PMID[24901948] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | Konya, Turkey | 2007-APR |
PMID[24901948] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | leaves | Chungbuk, Korea | n.a. |
PMID[25935644] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | root | n.a. |
PMID[25981820] |
NPO25653 | Spatholobus suberectus | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[26690274] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | latex | n.a. |
PMID[27294120] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | Root barks | n.a. | n.a. |
PMID[3097265] |
NPO18117 | Dalbergia odorifera | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[9525107] |
NPO23510 | Vicia faba | Species | Fabaceae | Eukaryota | Sprout Seedling | n.a. | n.a. | Database[FooDB] |
NPO23510 | Vicia faba | Species | Fabaceae | Eukaryota | Stem | n.a. | n.a. | Database[FooDB] |
NPO23510 | Vicia faba | Species | Fabaceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
NPO23510 | Vicia faba | Species | Fabaceae | Eukaryota | Flower | n.a. | n.a. | Database[FooDB] |
NPO23510 | Vicia faba | Species | Fabaceae | Eukaryota | Fruit | n.a. | n.a. | Database[FooDB] |
NPO23510 | Vicia faba | Species | Fabaceae | Eukaryota | Oil | n.a. | n.a. | Database[FooDB] |
NPO23510 | Vicia faba | Species | Fabaceae | Eukaryota | Seed | n.a. | n.a. | Database[FooDB] |
NPO223 | Rhaponticum carthamoides | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO25653 | Spatholobus suberectus | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO16682 | Cirsium chinense | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO3634 | Robinia pseudoacacia | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO18117 | Dalbergia odorifera | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO23510 | Vicia faba | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO25653 | Spatholobus suberectus | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO23510 | Vicia faba | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO223 | Rhaponticum carthamoides | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO18117 | Dalbergia odorifera | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO16682 | Cirsium chinense | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO3634 | Robinia pseudoacacia | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO4916 | Toxicodendron vernicifluum | Species | Anacardiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO223 | Rhaponticum carthamoides | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO23510 | Vicia faba | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO25653 | Spatholobus suberectus | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO18117 | Dalbergia odorifera | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO3634 | Robinia pseudoacacia | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO6361 | Turpinia arguta | Species | Staphyleaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO2188 | Dendrobium candidum | Species | Orchidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO25653 | Spatholobus suberectus | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO18117 | Dalbergia odorifera | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO4916 | Toxicodendron vernicifluum | Species | Anacardiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO26559 | Glycine soja | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO4330 | Crotalus atrox | Species | Viperidae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO7250 | Ventilago vitiensis | Species | Rhamnaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO18117 | Dalbergia odorifera | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO23510 | Vicia faba | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO23549 | Erysimum siliculosum | Species | Brassicaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO9726 | Panzeria canescens | Species | Tachinidae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO25653 | Spatholobus suberectus | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO8842 | Neurymenia fraxinifolia | Species | Rhodomelaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO15970 | Chrysanthemum uliginosum | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO26722 | Dorstenia dinklagei | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO10786 | Trichocereus werdermannianus | Species | Cactaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO10917 | Junceella gemmacea | Species | Ellisellidae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO8308 | Bryocaulon pseudosatoanum | Species | Parmeliaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO2188 | Dendrobium candidum | Species | Orchidaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO1973 | Conyza japonica | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO16682 | Cirsium chinense | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO3634 | Robinia pseudoacacia | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO28952 | Sapium haematospermum | Species | Euphorbiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO131 | Euphrasia stricta | Species | Orobanchaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO223 | Rhaponticum carthamoides | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO26531 | Aeschrion excelsa | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[UNPD] |
NPO4916 | Toxicodendron vernicifluum | Species | Anacardiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO6790 | Camchaya loloana | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO26403 | Brachymeris montana | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[UNPD] |
NPO8922 | Kaempferia rotunda | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO26881 | Croton zehntneri | Species | Euphorbiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPO23510 | NPC26697 | Other (raw) | Fruit | 0.351 | 0.002 | 0.7 | mg/100g | Database [DUKE] |
NPO23510 | NPC26697 | Raw | n.a. | 0.075000001 | n.a. | n.a. | mg/100g | Database [PHENOL EXPLORER] |
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT12 | Individual Protein | Human immunodeficiency virus type 1 integrase | Human immunodeficiency virus 1 | IC50 | = | 20000.0 | nM | PMID[510143] |
NPT25 | Cell Line | MT4 | Homo sapiens | CC50 | = | 5300.0 | nM | PMID[510143] |
NPT91 | Cell Line | KB | Homo sapiens | CC50 | = | 9100.0 | nM | PMID[510143] |
NPT183 | Individual Protein | Arachidonate 5-lipoxygenase | Rattus norvegicus | IC50 | = | 4.6 | nM | PMID[510145] |
NPT12 | Individual Protein | Human immunodeficiency virus type 1 integrase | Human immunodeficiency virus 1 | IC50 | = | 19952.62 | nM | PMID[510146] |
NPT1333 | Individual Protein | Enoyl-acyl-carrier protein reductase | Plasmodium falciparum | IC50 | = | 12500.0 | nM | PMID[510147] |
NPT1573 | Individual Protein | Enoyl-[acyl-carrier-protein] reductase | Escherichia coli K-12 | IC50 | = | 30000.0 | nM | PMID[510147] |
NPT1333 | Individual Protein | Enoyl-acyl-carrier protein reductase | Plasmodium falciparum | Ki | = | 5500.0 | nM | PMID[510147] |
NPT1333 | Individual Protein | Enoyl-acyl-carrier protein reductase | Plasmodium falciparum | Ki | = | 2970.0 | nM | PMID[510147] |
NPT1333 | Individual Protein | Enoyl-acyl-carrier protein reductase | Plasmodium falciparum | Ki | = | 14.0 | nM | PMID[510147] |
NPT202 | Individual Protein | Protease | Human immunodeficiency virus 1 | Inhibition | = | 50.0 | % | PMID[510148] |
NPT285 | Individual Protein | Epidermal growth factor receptor erbB1 | Homo sapiens | IC50 | = | 16000.0 | nM | PMID[510149] |
NPT36 | Individual Protein | Tyrosine-protein kinase SRC | Homo sapiens | IC50 | = | 65000.0 | nM | PMID[510149] |
NPT1371 | Individual Protein | Cyclin-dependent kinase 2 | Homo sapiens | Kd | = | 100000.0 | nM | PMID[510149] |
NPT285 | Individual Protein | Epidermal growth factor receptor erbB1 | Homo sapiens | IC50 | = | 8000.0 | nM | PMID[510150] |
NPT36 | Individual Protein | Tyrosine-protein kinase SRC | Homo sapiens | IC50 | = | 65000.0 | nM | PMID[510150] |
NPT36 | Individual Protein | Tyrosine-protein kinase SRC | Homo sapiens | Inhibition | = | 9.1 | % | PMID[510151] |
NPT1478 | Individual Protein | Vascular endothelial growth factor receptor 2 | Homo sapiens | Inhibition | = | 48.3 | % | PMID[510151] |
NPT1479 | Individual Protein | Stem cell growth factor receptor | Homo sapiens | Inhibition | = | 15.1 | % | PMID[510151] |
NPT285 | Individual Protein | Epidermal growth factor receptor erbB1 | Homo sapiens | Inhibition | = | 3.0 | % | PMID[510151] |
NPT1480 | Individual Protein | Fibroblast growth factor receptor 1 | Homo sapiens | Inhibition | = | 68.5 | % | PMID[510151] |
NPT1481 | Individual Protein | Fibroblast growth factor receptor 2 | Homo sapiens | Inhibition | = | 3.0 | % | PMID[510151] |
NPT1337 | Individual Protein | Hepatocyte growth factor receptor | Homo sapiens | Inhibition | = | 81.7 | % | PMID[510151] |
NPT276 | Individual Protein | Angiotensin-converting enzyme | Oryctolagus cuniculus | IC50 | = | 730.0 | nM | PMID[510154] |
NPT61 | Individual Protein | Beta-glucocerebrosidase | Homo sapiens | Potency | n.a. | 10000.0 | nM | PMID[510155] |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | 17.5 | % | PMID[510157] |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | 14.8 | % | PMID[510157] |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | -7.3 | % | PMID[510157] |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | -80.8 | % | PMID[510157] |
NPT276 | Individual Protein | Angiotensin-converting enzyme | Oryctolagus cuniculus | IC50 | = | 730000.0 | nM | PMID[510158] |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | n.a. | 44668.4 | nM | PMID[510155] |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | n.a. | 21192.3 | nM | PMID[510155] |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | n.a. | 6137.62 | nM | PMID[510159] |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | n.a. | 14521.12 | nM | PMID[510159] |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | n.a. | 18030.18 | nM | PMID[510159] |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | n.a. | 16672.47 | nM | PMID[510159] |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | n.a. | 14028.14 | nM | PMID[510159] |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | n.a. | 15739.83 | nM | PMID[510159] |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | n.a. | 3288.52 | nM | PMID[510159] |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | n.a. | 9099.13 | nM | PMID[510159] |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | n.a. | 11194.38 | nM | PMID[510159] |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | n.a. | 11641.26 | nM | PMID[510159] |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | n.a. | 13931.57 | nM | PMID[510159] |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | n.a. | 4265.8 | nM | PMID[510159] |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | n.a. | 17660.38 | nM | PMID[510159] |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | n.a. | 15417.0 | nM | PMID[510159] |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | n.a. | 7638.36 | nM | PMID[510159] |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | n.a. | 17378.01 | nM | PMID[510159] |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | n.a. | 17418.07 | nM | PMID[510159] |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | n.a. | 9246.98 | nM | PMID[510159] |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | n.a. | 17378.01 | nM | PMID[510159] |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | n.a. | 17906.06 | nM | PMID[510159] |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | n.a. | 10616.96 | nM | PMID[510159] |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | n.a. | 18492.69 | nM | PMID[510159] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | n.a. | 15848.93 | nM | PMID[510159] |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | n.a. | 7095.78 | nM | PMID[510159] |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | n.a. | 19408.86 | nM | PMID[510159] |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | n.a. | 8531.0 | nM | PMID[510159] |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | n.a. | 14028.14 | nM | PMID[510159] |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | n.a. | 2254.24 | nM | PMID[510159] |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | n.a. | 10162.49 | nM | PMID[510159] |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | n.a. | 16143.59 | nM | PMID[510159] |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | n.a. | 16255.49 | nM | PMID[510159] |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | n.a. | 12246.16 | nM | PMID[510159] |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | n.a. | 10471.29 | nM | PMID[510159] |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | n.a. | 19054.61 | nM | PMID[510159] |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | n.a. | 8260.38 | nM | PMID[510159] |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | n.a. | 9268.3 | nM | PMID[510159] |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | n.a. | 14859.36 | nM | PMID[510159] |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | n.a. | 17060.82 | nM | PMID[510159] |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | n.a. | 17100.15 | nM | PMID[510159] |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | n.a. | 25003.45 | nM | PMID[510159] |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | n.a. | 11142.95 | nM | PMID[510159] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | n.a. | 13001.7 | nM | PMID[510159] |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | n.a. | 16255.49 | nM | PMID[510159] |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | n.a. | 26853.44 | nM | PMID[510159] |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | n.a. | 14825.18 | nM | PMID[510159] |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | n.a. | 19588.45 | nM | PMID[510159] |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | n.a. | 3981.07 | nM | PMID[510159] |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | n.a. | 15739.83 | nM | PMID[510159] |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | n.a. | 2471.72 | nM | PMID[510159] |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | n.a. | 14354.89 | nM | PMID[510159] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | n.a. | 15240.53 | nM | PMID[510159] |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | n.a. | 16865.53 | nM | PMID[510159] |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | n.a. | 9078.21 | nM | PMID[510159] |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | n.a. | 10495.42 | nM | PMID[510159] |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | n.a. | 15205.48 | nM | PMID[510159] |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | n.a. | 22335.72 | nM | PMID[510159] |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | n.a. | 11994.99 | nM | PMID[510159] |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | n.a. | 19408.86 | nM | PMID[510159] |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | n.a. | 15559.66 | nM | PMID[510159] |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | n.a. | 20796.97 | nM | PMID[510159] |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | n.a. | 13931.57 | nM | PMID[510159] |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | n.a. | 3749.73 | nM | PMID[510159] |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | n.a. | 17458.22 | nM | PMID[510159] |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | n.a. | 17338.04 | nM | PMID[510159] |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | n.a. | 14454.4 | nM | PMID[510159] |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | n.a. | 12189.9 | nM | PMID[510159] |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | n.a. | 14454.4 | nM | PMID[510159] |
NPT732 | Cell Line | HOP-18 | Homo sapiens | GI50 | n.a. | 16557.7 | nM | PMID[510159] |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | 10.05 | % | PMID[510161] |
NPT183 | Individual Protein | Arachidonate 5-lipoxygenase | Rattus norvegicus | IC50 | = | 4.6 | nM | PMID[510165] |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | n.a. | 19952.6 | nM | PMID[510155] |
NPT441 | Individual Protein | Cytochrome P450 19A1 | Homo sapiens | Activity | = | 87.5 | % | PMID[510166] |
NPT276 | Individual Protein | Angiotensin-converting enzyme | Oryctolagus cuniculus | IC50 | = | 730000000.0 | nM | PMID[510168] |
NPT1310 | Individual Protein | Xanthine dehydrogenase | Bos taurus | IC50 | = | 1300.0 | nM | PMID[510169] |
NPT113 | Cell Line | RAW264.7 | Mus musculus | IC50 | = | 5300.0 | nM | PMID[510171] |
NPT34 | Cell Line | BV-2 | Mus musculus | IC50 | = | 4300.0 | nM | PMID[510171] |
NPT804 | Cell Line | HT-22 | Mus musculus | FC | = | 1.22 | n.a. | PMID[510172] |
NPT804 | Cell Line | HT-22 | Mus musculus | FC | = | 0.69 | n.a. | PMID[510172] |
NPT804 | Cell Line | HT-22 | Mus musculus | Activity | = | 59.79 | % | PMID[510172] |
NPT34 | Cell Line | BV-2 | Mus musculus | IC50 | = | 10900.0 | nM | PMID[510173] |
NPT1588 | Individual Protein | Estradiol 17-beta-dehydrogenase 2 | Homo sapiens | IC50 | = | 7300.0 | nM | PMID[510174] |
NPT461 | Cell Line | PANC-1 | Homo sapiens | PC50 | = | 67.0 | uM | PMID[510176] |
NPT2219 | Cell Line | C2C12 | Mus musculus | IC10 | = | 3.99 | ug ml-1 | PMID[510181] |
NPT2219 | Cell Line | C2C12 | Mus musculus | IC50 | = | 18.99 | ug.mL-1 | PMID[510181] |
NPT27 | Others | Unspecified | Fold increase | = | 2.2 | n.a. | PMID[510143] | |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 66000.0 | nM | PMID[510144] |
NPT27 | Others | Unspecified | IC50 | = | 16000.0 | nM | PMID[510144] | |
NPT1476 | Protein Family | Cyclooxygenase | Homo sapiens | IC50 | = | 120000.0 | nM | PMID[510145] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 40.0 | % | PMID[510145] |
NPT2 | Others | Unspecified | IC50 | > | 500000.0 | nM | PMID[510149] | |
NPT2 | Others | Unspecified | IC50 | > | 20000.0 | nM | PMID[510152] | |
NPT35 | Others | n.a. | Activity | = | 2.42 | MU | PMID[510153] | |
NPT35 | Others | n.a. | Activity | = | 2.27 | MU | PMID[510153] | |
NPT35 | Others | n.a. | Activity | = | 119.5 | mg/L | PMID[510153] | |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 17782.8 | nM | PMID[510155] |
NPT2 | Others | Unspecified | IC50 | > | 20000.0 | nM | PMID[510156] | |
NPT27 | Others | Unspecified | Activity | < | 5.0 | % | PMID[510156] | |
NPT888 | Individual Protein | 78 kDa glucose-regulated protein | Homo sapiens | Potency | n.a. | 44668.4 | nM | PMID[510155] |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | -0.63 | % | PMID[510161] |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 14.36 | % | PMID[510162] |
NPT68 | Individual Protein | Aldose reductase | Rattus norvegicus | IC50 | = | 450.0 | nM | PMID[510163] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 35100.0 | nM | PMID[510164] |
NPT1559 | Protein Family | Cyclooxygenase | Rattus norvegicus | IC50 | = | 4.6 | nM | PMID[510165] |
NPT983 | Protein Complex | Nuclear factor NF-kappa-B complex | Homo sapiens | IC50 | = | 38000.0 | nM | PMID[510167] |
NPT35 | Others | n.a. | Activity | = | 90.0 | % | PMID[510169] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 71.0 | % | PMID[510169] |
NPT35 | Others | n.a. | IC50 | = | 3.3 | ug.mL-1 | PMID[510170] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 92.46 | % | PMID[510172] |
NPT21770 | PROTEIN FAMILY | MAP kinase p38 | Mus musculus | FC | = | 0.75 | n.a. | PMID[510172] |
NPT2 | Others | Unspecified | FC | = | 1.49 | n.a. | PMID[510172] | |
NPT2 | Others | Unspecified | FC | = | 0.73 | n.a. | PMID[510172] | |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | -4.59 | % | PMID[510175] |
NPT20556 | SINGLE PROTEIN | Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 8.451 | % | PMID[510177] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | -0.13 | % | PMID[510178] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 20000.0 | nM | PMID[510180] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 19952.62 | nM | PMID[510180] |
NPT2 | Others | Unspecified | Inhibition | = | 20.0 | % | PMID[510182] | |
NPT2 | Others | Unspecified | IC50 | = | 43300.0 | nM | PMID[510182] | |
NPT27 | Others | Unspecified | Stability | = | 9.93 | % | PMID[510182] | |
NPT27 | Others | Unspecified | Stability | = | 18.1 | % | PMID[510182] | |
NPT27 | Others | Unspecified | Stability | = | 61.6 | % | PMID[510182] | |
NPT35 | Others | n.a. | pKa | = | 7.96 | n.a. | PMID[510182] | |
NPT35 | Others | n.a. | LogP | = | 0.42 | n.a. | PMID[510182] | |
NPT27 | Others | Unspecified | logPapp | = | -5.35 | n.a. | PMID[510182] | |
NPT35 | Others | n.a. | Solubility | = | 21.0 | ug.mL-1 | PMID[510182] | |
NPT27 | Others | Unspecified | Tmax | = | 0.1 | hr | PMID[510182] | |
NPT27 | Others | Unspecified | Tmax | = | 0.3 | hr | PMID[510182] | |
NPT27 | Others | Unspecified | Cmax | = | 0.041 | ug.mL-1 | PMID[510182] | |
NPT27 | Others | Unspecified | Cmax | = | 0.601 | ug.mL-1 | PMID[510182] | |
NPT27 | Others | Unspecified | Cmax | = | 0.083 | ug.mL-1 | PMID[510182] | |
NPT27 | Others | Unspecified | AUC | = | 6.7 | ng.hr.mL-1 | PMID[510182] | |
NPT27 | Others | Unspecified | AUC | = | 251.0 | ng.hr.mL-1 | PMID[510182] | |
NPT27 | Others | Unspecified | AUC | = | 141.0 | ng.hr.mL-1 | PMID[510182] | |
NPT27 | Others | Unspecified | F | = | 37.0 | % | PMID[510182] | |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 52.0 | % | PMID[510182] |
NPT27 | Others | Unspecified | F | = | 15.0 | % | PMID[510182] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC26697 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9919 | High Similarity | NPC469526 |
0.9919 | High Similarity | NPC34070 |
0.984 | High Similarity | NPC135801 |
0.9839 | High Similarity | NPC233056 |
0.9535 | High Similarity | NPC264112 |
0.9535 | High Similarity | NPC194764 |
0.9535 | High Similarity | NPC65005 |
0.9524 | High Similarity | NPC244441 |
0.9512 | High Similarity | NPC13238 |
0.9462 | High Similarity | NPC290030 |
0.944 | High Similarity | NPC107672 |
0.9389 | High Similarity | NPC175552 |
0.936 | High Similarity | NPC8745 |
0.9318 | High Similarity | NPC472903 |
0.928 | High Similarity | NPC10926 |
0.9268 | High Similarity | NPC224273 |
0.9268 | High Similarity | NPC115159 |
0.9268 | High Similarity | NPC19174 |
0.9268 | High Similarity | NPC73532 |
0.9268 | High Similarity | NPC45438 |
0.9268 | High Similarity | NPC143427 |
0.9268 | High Similarity | NPC267552 |
0.9248 | High Similarity | NPC203063 |
0.9194 | High Similarity | NPC32032 |
0.9194 | High Similarity | NPC133909 |
0.9187 | High Similarity | NPC297186 |
0.9179 | High Similarity | NPC472904 |
0.9167 | High Similarity | NPC170742 |
0.9113 | High Similarity | NPC242895 |
0.9113 | High Similarity | NPC156139 |
0.9111 | High Similarity | NPC301178 |
0.9111 | High Similarity | NPC284556 |
0.9091 | High Similarity | NPC223836 |
0.9044 | High Similarity | NPC238629 |
0.9044 | High Similarity | NPC287722 |
0.9044 | High Similarity | NPC254659 |
0.9044 | High Similarity | NPC471417 |
0.9032 | High Similarity | NPC248363 |
0.9024 | High Similarity | NPC158222 |
0.8984 | High Similarity | NPC156539 |
0.8984 | High Similarity | NPC214620 |
0.8978 | High Similarity | NPC142165 |
0.8978 | High Similarity | NPC242893 |
0.8978 | High Similarity | NPC38065 |
0.8952 | High Similarity | NPC159525 |
0.8913 | High Similarity | NPC70136 |
0.8872 | High Similarity | NPC72918 |
0.8871 | High Similarity | NPC161617 |
0.8846 | High Similarity | NPC474998 |
0.8846 | High Similarity | NPC109123 |
0.8846 | High Similarity | NPC92624 |
0.8841 | High Similarity | NPC279121 |
0.8837 | High Similarity | NPC98254 |
0.8837 | High Similarity | NPC105157 |
0.8837 | High Similarity | NPC30501 |
0.8837 | High Similarity | NPC23126 |
0.8837 | High Similarity | NPC103356 |
0.8837 | High Similarity | NPC162612 |
0.8837 | High Similarity | NPC72158 |
0.8837 | High Similarity | NPC266689 |
0.8837 | High Similarity | NPC100067 |
0.8837 | High Similarity | NPC190043 |
0.8837 | High Similarity | NPC169250 |
0.881 | High Similarity | NPC196976 |
0.8797 | High Similarity | NPC282780 |
0.8797 | High Similarity | NPC166480 |
0.8797 | High Similarity | NPC44437 |
0.879 | High Similarity | NPC40649 |
0.879 | High Similarity | NPC209486 |
0.8786 | High Similarity | NPC95864 |
0.8786 | High Similarity | NPC140840 |
0.8786 | High Similarity | NPC168803 |
0.8786 | High Similarity | NPC125449 |
0.8786 | High Similarity | NPC86847 |
0.8786 | High Similarity | NPC188074 |
0.8786 | High Similarity | NPC51443 |
0.8786 | High Similarity | NPC74881 |
0.8779 | High Similarity | NPC259942 |
0.8769 | High Similarity | NPC473017 |
0.8769 | High Similarity | NPC221777 |
0.8769 | High Similarity | NPC21305 |
0.8768 | High Similarity | NPC175013 |
0.8768 | High Similarity | NPC119663 |
0.876 | High Similarity | NPC267846 |
0.876 | High Similarity | NPC62952 |
0.8759 | High Similarity | NPC110419 |
0.8731 | High Similarity | NPC129752 |
0.873 | High Similarity | NPC146642 |
0.8723 | High Similarity | NPC203747 |
0.8723 | High Similarity | NPC19545 |
0.8723 | High Similarity | NPC196277 |
0.8723 | High Similarity | NPC287395 |
0.8723 | High Similarity | NPC183655 |
0.8723 | High Similarity | NPC194653 |
0.8723 | High Similarity | NPC118726 |
0.8723 | High Similarity | NPC43669 |
0.8723 | High Similarity | NPC218490 |
0.8723 | High Similarity | NPC12367 |
0.8723 | High Similarity | NPC80710 |
0.8723 | High Similarity | NPC272721 |
0.8723 | High Similarity | NPC254702 |
0.8723 | High Similarity | NPC139364 |
0.8722 | High Similarity | NPC294226 |
0.8714 | High Similarity | NPC20791 |
0.8714 | High Similarity | NPC179271 |
0.8705 | High Similarity | NPC257025 |
0.8702 | High Similarity | NPC102829 |
0.8702 | High Similarity | NPC120488 |
0.8696 | High Similarity | NPC312256 |
0.8692 | High Similarity | NPC116513 |
0.8686 | High Similarity | NPC50823 |
0.8676 | High Similarity | NPC61398 |
0.8676 | High Similarity | NPC416 |
0.8662 | High Similarity | NPC333691 |
0.8662 | High Similarity | NPC183959 |
0.8662 | High Similarity | NPC102003 |
0.8662 | High Similarity | NPC92722 |
0.8662 | High Similarity | NPC1612 |
0.8662 | High Similarity | NPC40290 |
0.8662 | High Similarity | NPC105512 |
0.8662 | High Similarity | NPC264550 |
0.8662 | High Similarity | NPC200060 |
0.8662 | High Similarity | NPC139293 |
0.8662 | High Similarity | NPC195763 |
0.8662 | High Similarity | NPC38545 |
0.8662 | High Similarity | NPC142876 |
0.8662 | High Similarity | NPC69430 |
0.8662 | High Similarity | NPC171916 |
0.8662 | High Similarity | NPC264289 |
0.8652 | High Similarity | NPC239312 |
0.8652 | High Similarity | NPC77378 |
0.8652 | High Similarity | NPC108406 |
0.8652 | High Similarity | NPC275772 |
0.8652 | High Similarity | NPC130230 |
0.8651 | High Similarity | NPC294037 |
0.8636 | High Similarity | NPC117609 |
0.8636 | High Similarity | NPC147757 |
0.8626 | High Similarity | NPC179898 |
0.8603 | High Similarity | NPC473391 |
0.8603 | High Similarity | NPC53414 |
0.8603 | High Similarity | NPC147418 |
0.8603 | High Similarity | NPC472364 |
0.8603 | High Similarity | NPC53206 |
0.8601 | High Similarity | NPC29231 |
0.8601 | High Similarity | NPC85131 |
0.8601 | High Similarity | NPC472279 |
0.8601 | High Similarity | NPC45873 |
0.8601 | High Similarity | NPC260582 |
0.8601 | High Similarity | NPC10467 |
0.8594 | High Similarity | NPC225710 |
0.8594 | High Similarity | NPC309765 |
0.8592 | High Similarity | NPC119059 |
0.8592 | High Similarity | NPC166036 |
0.8592 | High Similarity | NPC203077 |
0.8592 | High Similarity | NPC15329 |
0.8592 | High Similarity | NPC294852 |
0.8592 | High Similarity | NPC194856 |
0.8592 | High Similarity | NPC471907 |
0.8592 | High Similarity | NPC131451 |
0.8592 | High Similarity | NPC3036 |
0.8592 | High Similarity | NPC238279 |
0.8592 | High Similarity | NPC321011 |
0.8592 | High Similarity | NPC188679 |
0.8592 | High Similarity | NPC276930 |
0.8583 | High Similarity | NPC149246 |
0.8582 | High Similarity | NPC40524 |
0.8582 | High Similarity | NPC213485 |
0.8582 | High Similarity | NPC267205 |
0.8582 | High Similarity | NPC139074 |
0.8582 | High Similarity | NPC12377 |
0.8582 | High Similarity | NPC169749 |
0.8571 | High Similarity | NPC188814 |
0.8571 | High Similarity | NPC207732 |
0.8571 | High Similarity | NPC105213 |
0.8571 | High Similarity | NPC195262 |
0.8571 | High Similarity | NPC475042 |
0.8561 | High Similarity | NPC291078 |
0.8561 | High Similarity | NPC476119 |
0.856 | High Similarity | NPC150919 |
0.8542 | High Similarity | NPC154345 |
0.8542 | High Similarity | NPC35 |
0.8542 | High Similarity | NPC251110 |
0.8542 | High Similarity | NPC260895 |
0.8542 | High Similarity | NPC256406 |
0.8542 | High Similarity | NPC227485 |
0.8542 | High Similarity | NPC31363 |
0.854 | High Similarity | NPC212767 |
0.854 | High Similarity | NPC123714 |
0.8538 | High Similarity | NPC477454 |
0.8538 | High Similarity | NPC262671 |
0.8538 | High Similarity | NPC201728 |
0.8531 | High Similarity | NPC287101 |
0.8531 | High Similarity | NPC223579 |
0.8531 | High Similarity | NPC183950 |
0.8531 | High Similarity | NPC270465 |
0.8531 | High Similarity | NPC216318 |
0.8531 | High Similarity | NPC17286 |
0.8531 | High Similarity | NPC195351 |
0.8531 | High Similarity | NPC52005 |
0.8531 | High Similarity | NPC87125 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC26697 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.984 | High Similarity | NPD943 | Approved |
0.9091 | High Similarity | NPD651 | Clinical (unspecified phase) |
0.8841 | High Similarity | NPD1511 | Approved |
0.8714 | High Similarity | NPD1512 | Approved |
0.8594 | High Similarity | NPD9269 | Phase 2 |
0.8529 | High Similarity | NPD1509 | Clinical (unspecified phase) |
0.8394 | Intermediate Similarity | NPD1510 | Phase 2 |
0.837 | Intermediate Similarity | NPD1240 | Approved |
0.8356 | Intermediate Similarity | NPD1934 | Approved |
0.8311 | Intermediate Similarity | NPD3882 | Suspended |
0.8299 | Intermediate Similarity | NPD2801 | Approved |
0.8299 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.8281 | Intermediate Similarity | NPD9268 | Approved |
0.8248 | Intermediate Similarity | NPD1607 | Approved |
0.8175 | Intermediate Similarity | NPD230 | Phase 1 |
0.812 | Intermediate Similarity | NPD1470 | Approved |
0.8092 | Intermediate Similarity | NPD1201 | Approved |
0.8085 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8014 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8014 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7931 | Intermediate Similarity | NPD7390 | Discontinued |
0.7907 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7852 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7852 | Intermediate Similarity | NPD1164 | Approved |
0.7834 | Intermediate Similarity | NPD3818 | Discontinued |
0.7832 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7821 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7821 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7821 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7763 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7755 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7712 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7698 | Intermediate Similarity | NPD74 | Approved |
0.7698 | Intermediate Similarity | NPD9266 | Approved |
0.7692 | Intermediate Similarity | NPD5408 | Approved |
0.7692 | Intermediate Similarity | NPD5405 | Approved |
0.7692 | Intermediate Similarity | NPD5406 | Approved |
0.7692 | Intermediate Similarity | NPD5404 | Approved |
0.7687 | Intermediate Similarity | NPD6799 | Approved |
0.7673 | Intermediate Similarity | NPD7054 | Approved |
0.7635 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7625 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7625 | Intermediate Similarity | NPD7472 | Approved |
0.7619 | Intermediate Similarity | NPD9264 | Approved |
0.7619 | Intermediate Similarity | NPD9265 | Clinical (unspecified phase) |
0.7619 | Intermediate Similarity | NPD9263 | Approved |
0.7619 | Intermediate Similarity | NPD9267 | Approved |
0.7582 | Intermediate Similarity | NPD1465 | Phase 2 |
0.758 | Intermediate Similarity | NPD6232 | Discontinued |
0.7578 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7569 | Intermediate Similarity | NPD2935 | Discontinued |
0.7569 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7569 | Intermediate Similarity | NPD2796 | Approved |
0.7561 | Intermediate Similarity | NPD1242 | Phase 1 |
0.7548 | Intermediate Similarity | NPD7075 | Discontinued |
0.7548 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7547 | Intermediate Similarity | NPD7473 | Discontinued |
0.7531 | Intermediate Similarity | NPD7251 | Discontinued |
0.7517 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD9493 | Approved |
0.7485 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD3750 | Approved |
0.7482 | Intermediate Similarity | NPD9494 | Approved |
0.7468 | Intermediate Similarity | NPD7819 | Suspended |
0.7468 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7464 | Intermediate Similarity | NPD1203 | Approved |
0.7432 | Intermediate Similarity | NPD6190 | Approved |
0.7429 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7413 | Intermediate Similarity | NPD447 | Suspended |
0.7386 | Intermediate Similarity | NPD6599 | Discontinued |
0.7378 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7365 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7364 | Intermediate Similarity | NPD3022 | Approved |
0.7364 | Intermediate Similarity | NPD3021 | Approved |
0.7357 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7348 | Intermediate Similarity | NPD9281 | Approved |
0.7342 | Intermediate Similarity | NPD5494 | Approved |
0.7338 | Intermediate Similarity | NPD7411 | Suspended |
0.7325 | Intermediate Similarity | NPD3749 | Approved |
0.7319 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7308 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7303 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7302 | Intermediate Similarity | NPD9261 | Approved |
0.729 | Intermediate Similarity | NPD6801 | Discontinued |
0.7279 | Intermediate Similarity | NPD2344 | Approved |
0.7278 | Intermediate Similarity | NPD919 | Approved |
0.7267 | Intermediate Similarity | NPD3300 | Phase 2 |
0.7259 | Intermediate Similarity | NPD9545 | Approved |
0.7256 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7222 | Intermediate Similarity | NPD1613 | Approved |
0.7222 | Intermediate Similarity | NPD846 | Approved |
0.7222 | Intermediate Similarity | NPD940 | Approved |
0.7222 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7206 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.7205 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7197 | Intermediate Similarity | NPD5402 | Approved |
0.719 | Intermediate Similarity | NPD5403 | Approved |
0.7188 | Intermediate Similarity | NPD1247 | Approved |
0.7181 | Intermediate Similarity | NPD1243 | Approved |
0.7181 | Intermediate Similarity | NPD2800 | Approved |
0.7171 | Intermediate Similarity | NPD5401 | Approved |
0.7143 | Intermediate Similarity | NPD3748 | Approved |
0.7133 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7123 | Intermediate Similarity | NPD6651 | Approved |
0.7122 | Intermediate Similarity | NPD9717 | Approved |
0.7086 | Intermediate Similarity | NPD2309 | Approved |
0.7083 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7083 | Intermediate Similarity | NPD3764 | Approved |
0.7081 | Intermediate Similarity | NPD6959 | Discontinued |
0.7059 | Intermediate Similarity | NPD2532 | Approved |
0.7059 | Intermediate Similarity | NPD2534 | Approved |
0.7059 | Intermediate Similarity | NPD2533 | Approved |
0.7055 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7044 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7042 | Intermediate Similarity | NPD2798 | Approved |
0.7039 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.703 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.703 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7027 | Intermediate Similarity | NPD2799 | Discontinued |
0.7006 | Intermediate Similarity | NPD6559 | Discontinued |
0.698 | Remote Similarity | NPD9570 | Approved |
0.697 | Remote Similarity | NPD4750 | Phase 3 |
0.6968 | Remote Similarity | NPD920 | Approved |
0.6966 | Remote Similarity | NPD2313 | Discontinued |
0.6966 | Remote Similarity | NPD411 | Approved |
0.6954 | Remote Similarity | NPD7421 | Clinical (unspecified phase) |
0.6948 | Remote Similarity | NPD642 | Clinical (unspecified phase) |
0.6939 | Remote Similarity | NPD1933 | Approved |
0.6929 | Remote Similarity | NPD1547 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD258 | Approved |
0.6923 | Remote Similarity | NPD257 | Approved |
0.6918 | Remote Similarity | NPD520 | Approved |
0.6908 | Remote Similarity | NPD8166 | Discontinued |
0.6908 | Remote Similarity | NPD4628 | Phase 3 |
0.6883 | Remote Similarity | NPD6143 | Clinical (unspecified phase) |
0.6879 | Remote Similarity | NPD3226 | Approved |
0.6879 | Remote Similarity | NPD3455 | Phase 2 |
0.6875 | Remote Similarity | NPD9569 | Approved |
0.6867 | Remote Similarity | NPD6099 | Approved |
0.6867 | Remote Similarity | NPD6100 | Approved |
0.6846 | Remote Similarity | NPD1237 | Approved |
0.6845 | Remote Similarity | NPD5953 | Discontinued |
0.6842 | Remote Similarity | NPD2654 | Approved |
0.6828 | Remote Similarity | NPD6832 | Phase 2 |
0.6824 | Remote Similarity | NPD1899 | Clinical (unspecified phase) |
0.6821 | Remote Similarity | NPD2346 | Discontinued |
0.6821 | Remote Similarity | NPD7266 | Discontinued |
0.6812 | Remote Similarity | NPD5536 | Phase 2 |
0.6809 | Remote Similarity | NPD422 | Phase 1 |
0.6791 | Remote Similarity | NPD9280 | Clinical (unspecified phase) |
0.6786 | Remote Similarity | NPD2932 | Approved |
0.6786 | Remote Similarity | NPD3019 | Approved |
0.6766 | Remote Similarity | NPD3751 | Discontinued |
0.6763 | Remote Similarity | NPD1548 | Phase 1 |
0.6761 | Remote Similarity | NPD1608 | Approved |
0.6761 | Remote Similarity | NPD3972 | Approved |
0.676 | Remote Similarity | NPD7501 | Clinical (unspecified phase) |
0.6746 | Remote Similarity | NPD2934 | Approved |
0.6746 | Remote Similarity | NPD2933 | Approved |
0.6741 | Remote Similarity | NPD228 | Approved |
0.6726 | Remote Similarity | NPD6020 | Phase 2 |
0.6726 | Remote Similarity | NPD7286 | Phase 2 |
0.6724 | Remote Similarity | NPD8397 | Clinical (unspecified phase) |
0.6709 | Remote Similarity | NPD1653 | Approved |
0.6693 | Remote Similarity | NPD2860 | Approved |
0.6693 | Remote Similarity | NPD2859 | Approved |
0.6691 | Remote Similarity | NPD9377 | Approved |
0.6691 | Remote Similarity | NPD9379 | Approved |
0.669 | Remote Similarity | NPD1610 | Phase 2 |
0.6689 | Remote Similarity | NPD4308 | Phase 3 |
0.6689 | Remote Similarity | NPD259 | Phase 1 |
0.6689 | Remote Similarity | NPD3299 | Clinical (unspecified phase) |
0.6688 | Remote Similarity | NPD1196 | Approved |
0.6688 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD4419 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD4357 | Discontinued |
0.6667 | Remote Similarity | NPD3020 | Approved |
0.6667 | Remote Similarity | NPD9537 | Phase 1 |
0.6667 | Remote Similarity | NPD1543 | Discontinued |
0.6667 | Remote Similarity | NPD7199 | Phase 2 |
0.6667 | Remote Similarity | NPD9536 | Phase 1 |
0.6667 | Remote Similarity | NPD9094 | Approved |
0.6647 | Remote Similarity | NPD1220 | Phase 1 |
0.6646 | Remote Similarity | NPD6234 | Discontinued |
0.6644 | Remote Similarity | NPD825 | Approved |
0.6644 | Remote Similarity | NPD3018 | Phase 2 |
0.6644 | Remote Similarity | NPD826 | Approved |
0.6623 | Remote Similarity | NPD1195 | Approved |
0.6622 | Remote Similarity | NPD3268 | Approved |
0.6609 | Remote Similarity | NPD8150 | Discontinued |
0.6601 | Remote Similarity | NPD1471 | Phase 3 |
0.66 | Remote Similarity | NPD275 | Approved |
0.66 | Remote Similarity | NPD274 | Approved |
0.66 | Remote Similarity | NPD555 | Phase 2 |
0.6597 | Remote Similarity | NPD1755 | Approved |
0.6587 | Remote Similarity | NPD7184 | Clinical (unspecified phase) |
0.6587 | Remote Similarity | NPD5242 | Approved |
0.6564 | Remote Similarity | NPD2296 | Approved |
0.6564 | Remote Similarity | NPD4288 | Approved |
0.6562 | Remote Similarity | NPD844 | Approved |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.